Affiliation
Molecular Oncology Group, The Paterson Institute for Cancer Research, Manchester M20 4, UK.Issue Date
2013-06-10
Metadata
Show full item recordAbstract
The scaffold protein IQGAP1 regulates cell signaling through the RAF/MEK/ERK pathway. Recent data show that cancer cells in which the RAF/MEK/ERK pathway is activated are particularly sensitive to the disruption of IQGAP1 function. IQGAP drugs may be particularly effective in tumors that develop resistance to existing pathway drugs.Citation
Mind the IQGAP. 2013, 23 (6):715-7 Cancer CellJournal
Cancer CellDOI
10.1016/j.ccr.2013.05.017PubMed ID
23763998Type
ArticleLanguage
enISSN
1878-3686ae974a485f413a2113503eed53cd6c53
10.1016/j.ccr.2013.05.017
Scopus Count
Collections
Related articles
- Targeting RAF-MEK-ERK kinase-scaffold interactions in cancer.
- Authors: Stuart DD, Sellers WR
- Issue date: 2013 May
- IQGAP1 scaffold-kinase interaction blockade selectively targets RAS-MAP kinase-driven tumors.
- Authors: Jameson KL, Mazur PK, Zehnder AM, Zhang J, Zarnegar B, Sage J, Khavari PA
- Issue date: 2013 May
- IQGAP1 is a scaffold for mitogen-activated protein kinase signaling.
- Authors: Roy M, Li Z, Sacks DB
- Issue date: 2005 Sep
- Oncogenic Ras leads to Rho activation by activating the mitogen-activated protein kinase pathway and decreasing Rho-GTPase-activating protein activity.
- Authors: Chen JC, Zhuang S, Nguyen TH, Boss GR, Pilz RB
- Issue date: 2003 Jan 31
- The Ras GTPase-activating-like protein IQGAP1 mediates Nrf2 protein activation via the mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase (MEK)-ERK pathway.
- Authors: Cheung KL, Lee JH, Shu L, Kim JH, Sacks DB, Kong AN
- Issue date: 2013 Aug 2